Cooperative Centers on Human Immunology (CCHI)
Established in 2003 by NIAID, the long-term goal of the Cooperative Centers on Human Immunology (CCHI) program is to translate immunology research into clinical applications in humans in the areas of infectious disease and immune-mediated diseases.
CCHI supports mechanistic and hypothesis-testing studies to discover novel molecules, mechanisms, or regulatory pathways governing function of the human immune system in both healthy and vulnerable populations (i.e., across lifespan, organ/tissue transplant recipients, and pregnant women).
Main Areas of Focus
- To support research on human immune system regulation and function for the discovery and characterization of new principles of human immunology for the prevention and treatment of infectious and immune-mediated diseases.
- To support the development of new technologies to study the human immune system.
- To support the stable, flexible, centralized infrastructure needed to promote and coordinate multi-disciplinary research in human immunology.
Current Centers (FY19-FY23)
- Emory University
- La Jolla Institute for Immunology
- Massachusetts General Hospital
- Oklahoma Medical Research Foundation
- Rockefeller University
- Stanford University
- The Jackson Laboratory
- University of Alabama at Birmingham
The program will be renewed in the fiscal year of 2024 (FY24), RFA-AI-22-069